Wednesday, August 06, 2014 3:39:27 PM
Financial Time:Consensus recommendation
As of Aug 01, 2014, the consensus forecast amongst 5 polled investment analysts covering Cascade Microtech, Inc. advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Jun 03, 2014. The previous consensus forecast advised investors to purchase equity in Cascade Microtech, Inc..
2 BUY
3 OUTPERFORM
Earnigs estimate @.114 TDA
Market Cap (intraday)5: 193.15M
Enterprise Value (Aug 6, 2014)3: 164.34M
Trailing P/E (ttm, intraday): 12.93
Most Recent Quarter (mrq): Mar 31, 2014
Revenue (ttm): 126.35M
Gross Profit (ttm): 54.72M
EBITDA (ttm)6: 15.62M
Net Income Avl to Common (ttm): 14.26M
Diluted EPS (ttm): 0.92
Total Cash (mrq): 27.68M
Total Debt (mrq): 0.00
Shares Outstanding5: 16.23M
Float: 11.51M
Great opportunity to buy before the market close Less
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM